661 related articles for article (PubMed ID: 28445785)
21. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?
Vandenesch F; Lina G; Henry T
Front Cell Infect Microbiol; 2012; 2():12. PubMed ID: 22919604
[TBL] [Abstract][Full Text] [Related]
22. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.
Hamilton SM; Bryant AE; Carroll KC; Lockary V; Ma Y; McIndoo E; Miller LG; Perdreau-Remington F; Pullman J; Risi GF; Salmi DB; Stevens DL
Clin Infect Dis; 2007 Dec; 45(12):1550-8. PubMed ID: 18190315
[TBL] [Abstract][Full Text] [Related]
23. Identification of biologic agents to neutralize the bicomponent leukocidins of
Chan R; Buckley PT; O'Malley A; Sause WE; Alonzo F; Lubkin A; Boguslawski KM; Payne A; Fernandez J; Strohl WR; Whitaker B; Lynch AS; Torres VJ
Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651319
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular.
Melehani JH; James DB; DuMont AL; Torres VJ; Duncan JA
PLoS Pathog; 2015 Jun; 11(6):e1004970. PubMed ID: 26069969
[TBL] [Abstract][Full Text] [Related]
25. Severe infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus in infants: report of three cases and review of literature.
Montagnani C; Cocchi P; Bianchi L; Resti M; de Martino M; Galli L
Acta Paediatr; 2013 Jun; 102(6):e284-7. PubMed ID: 23551699
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner.
Perret M; Badiou C; Lina G; Burbaud S; Benito Y; Bes M; Cottin V; Couzon F; Juruj C; Dauwalder O; Goutagny N; Diep BA; Vandenesch F; Henry T
Cell Microbiol; 2012 Jul; 14(7):1019-36. PubMed ID: 22329718
[TBL] [Abstract][Full Text] [Related]
27. Recurrent primary abscesses in the hand: consider panton-valentine leukocidin-positive Staphylococcus aureus.
Wearn CM; Breuning EE; Chester DL
J Hand Surg Eur Vol; 2015 Mar; 40(3):314-5. PubMed ID: 23461911
[No Abstract] [Full Text] [Related]
28. Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.
DuMont AL; Torres VJ
Trends Microbiol; 2014 Jan; 22(1):21-7. PubMed ID: 24231517
[TBL] [Abstract][Full Text] [Related]
29. Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia.
Tam K; Lacey KA; Devlin JC; Coffre M; Sommerfield A; Chan R; O'Malley A; Koralov SB; Loke P; Torres VJ
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32602902
[TBL] [Abstract][Full Text] [Related]
30. Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.
Spaan AN; van Strijp JAG; Torres VJ
Nat Rev Microbiol; 2017 Jul; 15(7):435-447. PubMed ID: 28420883
[TBL] [Abstract][Full Text] [Related]
31. [Pore-forming leukotoxins from Staphylococcus aureus: variability of the target cells and 2 pharmacological processes].
Prévost G; Colin DA; Staali L; Baba Moussa L; Gravet A; Werner S; Sanni A; Meunier O; Monteil H
Pathol Biol (Paris); 1998 Jun; 46(6):435-41. PubMed ID: 9769878
[TBL] [Abstract][Full Text] [Related]
32. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcus aureus host cell invasion and post-invasion events.
Sinha B; Fraunholz M
Int J Med Microbiol; 2010 Feb; 300(2-3):170-5. PubMed ID: 19781990
[TBL] [Abstract][Full Text] [Related]
34. α-hemolysin of Staphylococcus aureus impairs thrombus formation.
Jahn K; Handtke S; Palankar R; Kohler TP; Wesche J; Wolff M; Bayer J; Wolz C; Greinacher A; Hammerschmidt S
J Thromb Haemost; 2022 Jun; 20(6):1464-1475. PubMed ID: 35303391
[TBL] [Abstract][Full Text] [Related]
35. A latex agglutination assay for specific detection of Panton-Valentine leukocidin.
Oishi K; Baba T; Nakatomi Y; Ito T; Hiramatsu K
J Microbiol Methods; 2008 Dec; 75(3):411-5. PubMed ID: 18718849
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity.
Trstenjak N; Milić D; Graewert MA; Rouha H; Svergun D; Djinović-Carugo K; Nagy E; Badarau A
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):317-327. PubMed ID: 31852826
[TBL] [Abstract][Full Text] [Related]
37. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
38. The adherens junctions control susceptibility to Staphylococcus aureus α-toxin.
Popov LM; Marceau CD; Starkl PM; Lumb JH; Shah J; Guerrera D; Cooper RL; Merakou C; Bouley DM; Meng W; Kiyonari H; Takeichi M; Galli SJ; Bagnoli F; Citi S; Carette JE; Amieva MR
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14337-42. PubMed ID: 26489655
[TBL] [Abstract][Full Text] [Related]
39. Panton-Valentine leukocidin-producing Staphylococcus aureus infection of the neck that mimicked disseminated malignancy.
Little M; Renny N
Br J Oral Maxillofac Surg; 2017 Oct; 55(8):862-863. PubMed ID: 28662921
[No Abstract] [Full Text] [Related]
40. SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins.
Anderson EE; Dyzenhaus S; Ilmain JK; Sullivan MJ; van Bakel H; Torres VJ
Infect Immun; 2023 Apr; 91(4):e0053222. PubMed ID: 36939325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
